Keith Baker - Net Worth and Insider Trading

Keith Baker Net Worth

The estimated net worth of Keith Baker is at least $12,369 dollars as of 2024-11-05. Keith Baker is the CFO of Kineta Inc and owns about 16,880 shares of Kineta Inc (KANT) stock worth over $12,369. Details can be seen in Keith Baker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith Baker has not made any transactions after 2023-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Keith Baker

To

Keith Baker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Keith Baker owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .

Click here to see the complete history of Keith Baker’s form 4 insider trades.

Insider Ownership Summary of Keith Baker

Ticker Comapny Transaction Date Type of Owner
YMTX Yumanity Therapeutics Inc 2022-12-16 Chief Financial Officer
KANT Kineta Inc 2023-09-18 Chief Financial Officer

Keith Baker Latest Holdings Summary

Keith Baker currently owns a total of 1 stock. Keith Baker owns 16,880 shares of Kineta Inc (KANT) as of September 18, 2023, with a value of $12,369.

Latest Holdings of Keith Baker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KANT Kineta Inc 2023-09-18 16,880 0.73 12,369

Holding Weightings of Keith Baker


Keith Baker Form 4 Trading Tracker

According to the SEC Form 4 filings, Keith Baker has made a total of 2 transactions in Kineta Inc (KANT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Kineta Inc is the acquisition of 5,000 shares on September 18, 2023, which cost Keith Baker around $10,650.

Insider Trading History of Keith Baker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Keith Baker Trading Performance

GuruFocus tracks the stock performance after each of Keith Baker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith Baker is 20.96%. GuruFocus also compares Keith Baker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith Baker within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Keith Baker's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Keith Baker

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 19.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Keith Baker Ownership Network

Ownership Network List of Keith Baker

No Data

Ownership Network Relation of Keith Baker

Insider Network Chart

Keith Baker Owned Company Details

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Keith Baker is the Chief Financial Officer of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and General Counsel Pauline Kenny .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Yumanity Therapeutics Inc Insider Transactions

No Available Data

Keith Baker Mailing Address

Above is the net worth, insider trading, and ownership report for Keith Baker. You might contact Keith Baker via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.